Utomilumab Biosimilar - Research Grade

Product Sizes

1 mg

ICH5014-1MG

5 mg

ICH5014-5MG

10 mg

ICH5014-10MG

20 mg

ICH5014-20MG

50 mg

ICH5014-50MG

100 mg

ICH5014-100MG

200 mg

ICH5014-200MG

500 mg

ICH5014-500MG

1 g

ICH5014-1G

About this Product

SKU:: ICH5014
Additional Names:: 4-1BB ligand receptor, T-cell antigen 4-1BB, Tnfrsf9, Ila, Ly63, CD137
Application:: Cell-based/Functional Assay
CE/IVD:: RUO
Clonality:: Recombinant Monoclonal
Concentration:: 5 mg/ml
Extra Details:: RUO Utomilumab is a fully-human IgG2 agonist mAb that selectively binds human 4-1BB/CD137, resulting in NF-K KappaB activation and downstream cytokine production in cell lines and primary lymphocytes. Utomilumab can induce human leukocyte proliferation and has demonstrated significant antitumor activity as a single agent in human peripheral blood lymphocyte (PBL) SCID xenograft tumor models.
Formulation:: Sterile, preservative-free, solution in PBS. BSA and Azide free.
Immunogen:: 4-1BB
Isotype:: IgG2, lambda
Purity:: >95%
Purification:: Protein A/G Purified
Reactivities:: Human
Shipping Conditions:: Blue Ice
Specificity:: Detects human CD137. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Utomilumab.
Storage Conditions:: -70[o]C Avoid freeze/thaw cycles.
Supplier:: ichorbio
Type:: Antibody: Biosimilar Antibody
Shipping Costs:: Free shipping to UK Customers

Basket